LBA68 FLAURA2: Safety and CNS outcomes of first-line (1L) osimertinib (osi) ± chemotherapy (CTx) in EGFRm advanced NSCLC
| Autor: | Planchard, D., Jänne, P.A., Cheng, Y., Lee, C.K., Laktionov, K., Yang, T-Y., Yu, Y., Kato, T., Jiang, L., Chewaskulyong, B., Lucien Geater, S., Maurel, J-M., Rojas, C., Havel, L., Shepherd, F.A., Tanaka, K., Ghiorghiu, D., Armenteros Monterroso, E., Huang, X., Yang, J.C-H. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1311-S1312 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|